164916-54-5

Basic information

• Product Name: (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE
• Synonyms: (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE
• CAS NO: 164916-54-5
• Molecular Formula: C15H14O5-2
• Molecular Weight: 274.26866
• Mol File: 164916-54-5.mol

Chemical Properties

• Boiling Point: 412.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.249±0.06 g/cm3(Predicted)
• CAS DataBase Reference: (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE(164916-54-5)
• EPA Substance Registry System: (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE(164916-54-5)

Safety Data

• Hazardous Substances Data: 164916-54-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
(CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE is used as a key intermediate in the synthesis of various pharmaceuticals due to its ability to react with a range of other compounds, facilitating the creation of new drug molecules with potential therapeutic applications.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE serves as a versatile building block for the synthesis of a variety of organic compounds, contributing to the development of new materials and chemical entities.
Used in Specialty Chemicals Production:
(CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE is utilized as a component in the production of specialty chemicals, where its unique properties allow for the creation of high-value products with specific applications in various industries.
Used in Organic Chemistry Research:
As a subject of study in organic chemistry research, (CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE aids in understanding reaction mechanisms and exploring new synthetic routes, thus advancing the field of organic chemistry.
Used as a Ligand in Metal-Catalyzed Reactions:
(CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE is employed as a ligand in metal-catalyzed reactions, enhancing the efficiency and selectivity of these processes and contributing to the development of novel chemical transformations.

Upstream product

• 122921-09-9 (+)-(1S-cis)-4-oxo-1,2-cyclopentanedicarboxylic acid monomethyl ester 
• 100-51-6 benzyl alcohol 
• 1445593-42-9 (1R,2R)-1-tert-butyl 2-methyl 4-oxocyclopentane-1,2-dicarboxylate 
• 1445591-99-0 (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid 
• 501-53-1 benzyl chloroformate 
• 115694-82-1 (1S,2S)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid 
• 73968-45-3 (1R,2S)-1-benzyl 2-methyl cyclohex-4-ene-1,2-dicarboxylate 

Downstream Products

• 1445591-71-8 (7,8-trans)-methyl 8-((2-(4-bromophenyl)-2-oxoethyl)carbamoyl)-1,4-dioxaspiro[4.4]nonane-7-carboxylate 
• 1445591-72-9 (7,8-trans)-methyl 8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxaspiro[4.4]nonane-7-carboxylate 
• 1445590-61-3 (S)-methyl 2-((7,8-trans)-8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxaspiro[4.4]nonane-7-carboxamido)-3-methylbutanoate 
• 1445591-67-2 (7,8-trans)-7-benzyl 8-methyl 1,4-dioxaspiro[4.4]nonane-7,8-dicarboxylate 
• 1445592-01-7 (7R,8R)-7-benzyl 8-methyl 1,4-dioxaspiro[4.4]nonane-7,8-dicarboxylate 
• 1445589-67-2 methyl ((2S)-3-methyl-1-(2-(5-(4-(2-((7S,8S)-8-((R)-3-methylmorpholine-4-carbonyl)-1,4-dioxaspiro[4.4]nonan-7-yl)-1H-imidazol-5-yl)-[1,1‘-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-1-oxobutan-2-yl)carbamate 
• 1445592-02-8 (7R,8R)-methyl 8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxaspiro[4.4]nonane-7-carboxylate 
• 1445590-82-8 ((7R,8R)-8-(5-(4-bromophenyl)-1H-imidazol-2-yl)-1,4-dioxaspiro[4.4]nonan-7-yl)((R)-3-methylmorpholino)methanone 
• 1445653-25-7 C₁₇H₁₇BrN₂O₄ 

Relevant articles and documents

NOVEL HEPATITIS C VIRUS INHIBITORS

The invention provides compounds of formula (I): wherein Rings A and A' are independently 5-membered optionally substituted aromatic heterocycles; Q is C(=O)NR1R1' or formula U is C(R4)2, O, S, S(=O)2, C(R4)2C(R4)2, CH2O, OCH2, CH2S, SCH2, CH2S(=O)2, S(=O)CH2 or C=C(Ru )2; X is CH2, CHR12, CR12R12, O, S, S(=O)2 or NRx; m is 0, 1, 2 or 3; n is 0, 1, 2 or 3; the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

Total synthesis of (+)-brefeldin C, (+)-nor-Me brefeldin A and (+)-4-epi-nor-Me brefeldin A

A total synthesis of (+)-brefeldin C (BFC) and two brefeldin A (BFA) analogues - (+)-nor-Me BFA and (+)-4-epi-nor-Me BFA - has been developed. Key features of the syntheses include desymmetrization of meso anhydrides, a Carreira reaction to control the ab

Enantioselective synthesis of an advanced intermediate for the synthesis of brefeldin A and analogues

A synthesis of methyl (1R,2R,4S)-2-[(E)-2-iodovinyl]-4-(methoxymethoxy) cyclopentanecarboxylate is described in nine steps from a prochiral anhydride. A desymmetrization reaction followed by an epimerization and a Takai reaction are the key steps of the t

α,β-Cyclic-β-benzamido hydroxamic acids: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)

Selective inhibitors of TNF-α Converting Enzyme (TACE) based on (1R,2S)-cyclopentyl, (3S,4S)-pyrrolidinyl, and (3R,4S)-tetrahydrofuranyl β-benzamido hydroxamic acids have been synthesized and evaluated. This study has led to the discovery of novel inhibitors whose profiles include activity against TACE in an enzyme assay, potency in the suppression of LPS-stimulated TNF-α in human whole blood, selectivity against a panel of MMPs and oral bioavailability.